A urologist who treated 65 patients after his license was suspended last November because he posed "a substantial danger to public health and safety" was ordered to spend 4 months in jail and pay a $10,000 fine.
Cell-cycle risk score is predictive of ADT benefit in prostate cancer
May 17th 2024"Prolaris precisely describes the difference in metastasis outcomes for men receiving monotherapy (RT) vs multimodal therapy (RT+ADT), and further tells me precisely what the risk of death is for a man on surveillance," says Jonathan D. Tward, MD, PhD.